nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—hypertension—adrenal gland cancer	0.697	1	CtDrD
Nicardipine—ABCB1—adrenal gland cancer	0.174	1	CbGaD
Nicardipine—CALM2—adrenal medulla—adrenal gland cancer	0.00473	0.126	CbGeAlD
Nicardipine—CALM1—adrenal medulla—adrenal gland cancer	0.0047	0.126	CbGeAlD
Nicardipine—CALM1—sympathetic nervous system—adrenal gland cancer	0.00313	0.0837	CbGeAlD
Nicardipine—CYP2C19—urine—adrenal gland cancer	0.00164	0.0437	CbGeAlD
Nicardipine—CYP2C9—urine—adrenal gland cancer	0.00127	0.0339	CbGeAlD
Nicardipine—CYP2E1—urine—adrenal gland cancer	0.0012	0.0321	CbGeAlD
Nicardipine—PDE1B—gonad—adrenal gland cancer	0.00115	0.0308	CbGeAlD
Nicardipine—PDE1B—adrenal gland—adrenal gland cancer	0.001	0.0269	CbGeAlD
Nicardipine—CYP3A4—urine—adrenal gland cancer	0.000967	0.0259	CbGeAlD
Nicardipine—PDE1A—gonad—adrenal gland cancer	0.000966	0.0258	CbGeAlD
Nicardipine—CYP2D6—urine—adrenal gland cancer	0.000952	0.0254	CbGeAlD
Nicardipine—PDE1A—adrenal gland—adrenal gland cancer	0.000842	0.0225	CbGeAlD
Nicardipine—CACNA1D—adrenal cortex—adrenal gland cancer	0.000752	0.0201	CbGeAlD
Nicardipine—CACNB2—cardiac atrium—adrenal gland cancer	0.000711	0.019	CbGeAlD
Nicardipine—CACNB2—pituitary gland—adrenal gland cancer	0.000695	0.0186	CbGeAlD
Nicardipine—CACNA1D—cardiac atrium—adrenal gland cancer	0.000622	0.0166	CbGeAlD
Nicardipine—CACNB2—adrenal gland—adrenal gland cancer	0.000621	0.0166	CbGeAlD
Nicardipine—CACNA1D—pituitary gland—adrenal gland cancer	0.000607	0.0162	CbGeAlD
Nicardipine—CACNA2D1—adrenal gland—adrenal gland cancer	0.000583	0.0156	CbGeAlD
Nicardipine—CALM3—adrenal cortex—adrenal gland cancer	0.000581	0.0155	CbGeAlD
Nicardipine—CACNA1C—cardiac atrium—adrenal gland cancer	0.000574	0.0153	CbGeAlD
Nicardipine—CACNA1C—pituitary gland—adrenal gland cancer	0.000561	0.015	CbGeAlD
Nicardipine—CACNA1D—adrenal gland—adrenal gland cancer	0.000543	0.0145	CbGeAlD
Nicardipine—CACNA1C—adrenal gland—adrenal gland cancer	0.000501	0.0134	CbGeAlD
Nicardipine—CALM3—cardiac atrium—adrenal gland cancer	0.000481	0.0129	CbGeAlD
Nicardipine—CALM3—pituitary gland—adrenal gland cancer	0.00047	0.0126	CbGeAlD
Nicardipine—CALM2—adrenal cortex—adrenal gland cancer	0.000456	0.0122	CbGeAlD
Nicardipine—CALM1—adrenal cortex—adrenal gland cancer	0.000454	0.0121	CbGeAlD
Nicardipine—CALM3—adrenal gland—adrenal gland cancer	0.00042	0.0112	CbGeAlD
Nicardipine—CALM2—gonad—adrenal gland cancer	0.000378	0.0101	CbGeAlD
Nicardipine—CALM2—cardiac atrium—adrenal gland cancer	0.000378	0.0101	CbGeAlD
Nicardipine—CALM1—gonad—adrenal gland cancer	0.000376	0.0101	CbGeAlD
Nicardipine—CALM1—cardiac atrium—adrenal gland cancer	0.000376	0.01	CbGeAlD
Nicardipine—CALM2—pituitary gland—adrenal gland cancer	0.000369	0.00986	CbGeAlD
Nicardipine—CALM1—pituitary gland—adrenal gland cancer	0.000367	0.00981	CbGeAlD
Nicardipine—CYP2B6—adrenal cortex—adrenal gland cancer	0.000339	0.00907	CbGeAlD
Nicardipine—CALM2—adrenal gland—adrenal gland cancer	0.000329	0.00881	CbGeAlD
Nicardipine—CALM1—adrenal gland—adrenal gland cancer	0.000328	0.00877	CbGeAlD
Nicardipine—ADRA1A—adrenal gland—adrenal gland cancer	0.000309	0.00826	CbGeAlD
Nicardipine—CYP2C8—pituitary gland—adrenal gland cancer	0.000306	0.00817	CbGeAlD
Nicardipine—CYP2B6—gonad—adrenal gland cancer	0.000281	0.00751	CbGeAlD
Nicardipine—Nisoldipine—ABCB1—adrenal gland cancer	0.000278	0.238	CrCbGaD
Nicardipine—Nitrendipine—ABCB1—adrenal gland cancer	0.00026	0.222	CrCbGaD
Nicardipine—CYP2B6—adrenal gland—adrenal gland cancer	0.000245	0.00655	CbGeAlD
Nicardipine—CYP2E1—adrenal gland—adrenal gland cancer	0.00023	0.00615	CbGeAlD
Nicardipine—Amlodipine—ABCB1—adrenal gland cancer	0.000223	0.192	CrCbGaD
Nicardipine—Felodipine—ABCB1—adrenal gland cancer	0.000207	0.177	CrCbGaD
Nicardipine—Nifedipine—ABCB1—adrenal gland cancer	0.0002	0.171	CrCbGaD
Nicardipine—ABCB1—adrenal cortex—adrenal gland cancer	0.000181	0.00485	CbGeAlD
Nicardipine—ABCB1—gonad—adrenal gland cancer	0.00015	0.00402	CbGeAlD
Nicardipine—ABCB1—pituitary gland—adrenal gland cancer	0.000147	0.00392	CbGeAlD
Nicardipine—ABCB1—adrenal gland—adrenal gland cancer	0.000131	0.0035	CbGeAlD
Nicardipine—CHRM3—Signaling Pathways—PRKACA—adrenal gland cancer	8.84e-06	9.78e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	8.76e-06	9.69e-05	CbGpPWpGaD
Nicardipine—CACNA1C—Metabolism—PTGS2—adrenal gland cancer	8.75e-06	9.67e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	8.73e-06	9.66e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—CDC42—adrenal gland cancer	8.68e-06	9.6e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—CDC42—adrenal gland cancer	8.68e-06	9.6e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—MED12—adrenal gland cancer	8.67e-06	9.59e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—MED12—adrenal gland cancer	8.59e-06	9.51e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TERT—adrenal gland cancer	8.57e-06	9.48e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—GNAS—adrenal gland cancer	8.57e-06	9.48e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PRKACA—adrenal gland cancer	8.57e-06	9.47e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PRKACA—adrenal gland cancer	8.57e-06	9.47e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	8.43e-06	9.32e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—ABCB1—adrenal gland cancer	8.41e-06	9.3e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CDC42—adrenal gland cancer	8.34e-06	9.22e-05	CbGpPWpGaD
Nicardipine—PDE1B—Disease—EGFR—adrenal gland cancer	8.23e-06	9.1e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	8.2e-06	9.06e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—POMC—adrenal gland cancer	8.17e-06	9.04e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	8.09e-06	8.95e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	8.07e-06	8.92e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TERT—adrenal gland cancer	8.06e-06	8.92e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IGF2—adrenal gland cancer	8.04e-06	8.89e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—GNAS—adrenal gland cancer	7.97e-06	8.81e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—CTNNB1—adrenal gland cancer	7.95e-06	8.8e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—BAD—adrenal gland cancer	7.79e-06	8.61e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IGF1R—adrenal gland cancer	7.77e-06	8.6e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	7.7e-06	8.52e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	7.68e-06	8.5e-05	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—CTNNB1—adrenal gland cancer	7.66e-06	8.47e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—SDHD—adrenal gland cancer	7.6e-06	8.41e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—RRM1—adrenal gland cancer	7.6e-06	8.41e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	7.53e-06	8.33e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	7.53e-06	8.32e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	7.5e-06	8.3e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—BAD—adrenal gland cancer	7.46e-06	8.25e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	7.43e-06	8.22e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	7.41e-06	8.19e-05	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—CTNNB1—adrenal gland cancer	7.41e-06	8.19e-05	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—CTNNB1—adrenal gland cancer	7.41e-06	8.19e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PRKACA—adrenal gland cancer	7.41e-06	8.19e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—GNAS—adrenal gland cancer	7.38e-06	8.16e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—CTNNB1—adrenal gland cancer	7.27e-06	8.04e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	7.25e-06	8.02e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—ABCB1—adrenal gland cancer	7.24e-06	8e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	7.23e-06	8e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—GNAS—adrenal gland cancer	7.22e-06	7.99e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—GNAS—adrenal gland cancer	7.21e-06	7.97e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—TERT—adrenal gland cancer	7.2e-06	7.96e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	7.19e-06	7.95e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—POMC—adrenal gland cancer	7.18e-06	7.94e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—GNAS—adrenal gland cancer	7.18e-06	7.94e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	7.17e-06	7.93e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PRKACA—adrenal gland cancer	7.16e-06	7.92e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PRKACA—adrenal gland cancer	7.16e-06	7.92e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	7.16e-06	7.92e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	7.14e-06	7.9e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	7.1e-06	7.85e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—BRAF—adrenal gland cancer	7.09e-06	7.84e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—ABCB1—adrenal gland cancer	7.09e-06	7.84e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	7.08e-06	7.83e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	7.07e-06	7.82e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—ABCB1—adrenal gland cancer	7.04e-06	7.79e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	7.01e-06	7.76e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—BAD—adrenal gland cancer	7.01e-06	7.76e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	6.99e-06	7.73e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—TERT—adrenal gland cancer	6.96e-06	7.7e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—TERT—adrenal gland cancer	6.96e-06	7.7e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—GNAS—adrenal gland cancer	6.94e-06	7.68e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—GNAS—adrenal gland cancer	6.94e-06	7.68e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	6.92e-06	7.66e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	6.9e-06	7.64e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—POMC—adrenal gland cancer	6.88e-06	7.61e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	6.88e-06	7.6e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling by GPCR—EGFR—adrenal gland cancer	6.87e-06	7.6e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—POMC—adrenal gland cancer	6.84e-06	7.57e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—ABCB1—adrenal gland cancer	6.81e-06	7.54e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—ABCB1—adrenal gland cancer	6.81e-06	7.54e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—BRAF—adrenal gland cancer	6.79e-06	7.51e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—BAD—adrenal gland cancer	6.78e-06	7.5e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	6.72e-06	7.43e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PRKACA—adrenal gland cancer	6.71e-06	7.42e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TERT—adrenal gland cancer	6.69e-06	7.4e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—POMC—adrenal gland cancer	6.62e-06	7.32e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—POMC—adrenal gland cancer	6.62e-06	7.32e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling by GPCR—EGFR—adrenal gland cancer	6.58e-06	7.28e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—BAD—adrenal gland cancer	6.56e-06	7.25e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—BAD—adrenal gland cancer	6.56e-06	7.25e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—POMC—adrenal gland cancer	6.47e-06	7.15e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—BRAF—adrenal gland cancer	6.38e-06	7.06e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	6.32e-06	6.99e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—EGFR—adrenal gland cancer	6.3e-06	6.97e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CDC42—adrenal gland cancer	6.28e-06	6.95e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	6.27e-06	6.93e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—BAD—adrenal gland cancer	6.26e-06	6.92e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—GNAS—adrenal gland cancer	6.24e-06	6.91e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—EGFR—adrenal gland cancer	6.19e-06	6.84e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	6.13e-06	6.78e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	6.13e-06	6.78e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CDC42—adrenal gland cancer	6.08e-06	6.72e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CDC42—adrenal gland cancer	6.08e-06	6.72e-05	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—EGFR—adrenal gland cancer	6.07e-06	6.71e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—BAD—adrenal gland cancer	6.06e-06	6.7e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—BAD—adrenal gland cancer	6.06e-06	6.7e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IGF2—adrenal gland cancer	6.05e-06	6.7e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	6.04e-06	6.68e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	6.02e-06	6.66e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—GNAS—adrenal gland cancer	6e-06	6.64e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	5.96e-06	6.59e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	5.94e-06	6.57e-05	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—EGFR—adrenal gland cancer	5.87e-06	6.49e-05	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—EGFR—adrenal gland cancer	5.87e-06	6.49e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IGF2—adrenal gland cancer	5.86e-06	6.48e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IGF2—adrenal gland cancer	5.86e-06	6.48e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IGF1R—adrenal gland cancer	5.85e-06	6.47e-05	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—EGFR—adrenal gland cancer	5.83e-06	6.44e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—BAD—adrenal gland cancer	5.82e-06	6.44e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—GNAS—adrenal gland cancer	5.81e-06	6.42e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—GNAS—adrenal gland cancer	5.81e-06	6.42e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—POMC—adrenal gland cancer	5.77e-06	6.38e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—EGFR—adrenal gland cancer	5.76e-06	6.37e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—BRAF—adrenal gland cancer	5.7e-06	6.3e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—MED12—adrenal gland cancer	5.67e-06	6.27e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IGF1R—adrenal gland cancer	5.66e-06	6.26e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IGF1R—adrenal gland cancer	5.66e-06	6.26e-05	CbGpPWpGaD
Nicardipine—CALM3—Hemostasis—TP53—adrenal gland cancer	5.66e-06	6.26e-05	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—EGFR—adrenal gland cancer	5.64e-06	6.23e-05	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—EGFR—adrenal gland cancer	5.64e-06	6.23e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—GNAS—adrenal gland cancer	5.57e-06	6.16e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—BRAF—adrenal gland cancer	5.51e-06	6.1e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—BRAF—adrenal gland cancer	5.51e-06	6.1e-05	CbGpPWpGaD
Nicardipine—CALM2—Hemostasis—TP53—adrenal gland cancer	5.47e-06	6.05e-05	CbGpPWpGaD
Nicardipine—CALM1—Hemostasis—TP53—adrenal gland cancer	5.47e-06	6.05e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	5.47e-06	6.05e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—GNAS—adrenal gland cancer	5.44e-06	6.02e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—POMC—adrenal gland cancer	5.37e-06	5.93e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—BRAF—adrenal gland cancer	5.3e-06	5.86e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—TP53—adrenal gland cancer	5.29e-06	5.85e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	5.25e-06	5.81e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	5.24e-06	5.79e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	5.18e-06	5.73e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	5.17e-06	5.72e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—EGFR—adrenal gland cancer	5.14e-06	5.68e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—GNAS—adrenal gland cancer	5.13e-06	5.67e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—CTNNB1—adrenal gland cancer	5.13e-06	5.67e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—GNAS—adrenal gland cancer	5.08e-06	5.62e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TERT—adrenal gland cancer	5.04e-06	5.57e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	5.03e-06	5.56e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	4.99e-06	5.51e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—POMC—adrenal gland cancer	4.97e-06	5.49e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—CTNNB1—adrenal gland cancer	4.91e-06	5.43e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TERT—adrenal gland cancer	4.87e-06	5.39e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TERT—adrenal gland cancer	4.87e-06	5.39e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—POMC—adrenal gland cancer	4.86e-06	5.38e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—POMC—adrenal gland cancer	4.85e-06	5.37e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	4.84e-06	5.35e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—TP53—adrenal gland cancer	4.84e-06	5.35e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—POMC—adrenal gland cancer	4.83e-06	5.34e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	4.83e-06	5.34e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	4.78e-06	5.29e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	4.78e-06	5.29e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	4.77e-06	5.27e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	4.77e-06	5.27e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	4.72e-06	5.22e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	4.71e-06	5.21e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—POMC—adrenal gland cancer	4.68e-06	5.17e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—POMC—adrenal gland cancer	4.68e-06	5.17e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	4.63e-06	5.13e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	4.62e-06	5.11e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—CTNNB1—adrenal gland cancer	4.61e-06	5.1e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—PTGS2—adrenal gland cancer	4.6e-06	5.09e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—PTGS2—adrenal gland cancer	4.6e-06	5.09e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	4.57e-06	5.06e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	4.56e-06	5.05e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—CTNNB1—adrenal gland cancer	4.46e-06	4.93e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—PTGS2—adrenal gland cancer	4.45e-06	4.92e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—PTGS2—adrenal gland cancer	4.45e-06	4.92e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—BAD—adrenal gland cancer	4.38e-06	4.85e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—CTNNB1—adrenal gland cancer	4.32e-06	4.77e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—CTNNB1—adrenal gland cancer	4.32e-06	4.77e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—BAD—adrenal gland cancer	4.24e-06	4.69e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—BAD—adrenal gland cancer	4.24e-06	4.69e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—POMC—adrenal gland cancer	4.2e-06	4.65e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	4.14e-06	4.57e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—CTNNB1—adrenal gland cancer	4.12e-06	4.55e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—EGFR—adrenal gland cancer	4.06e-06	4.49e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—POMC—adrenal gland cancer	4.04e-06	4.47e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—BRAF—adrenal gland cancer	3.99e-06	4.41e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—CTNNB1—adrenal gland cancer	3.98e-06	4.41e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—CTNNB1—adrenal gland cancer	3.98e-06	4.41e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PTGS2—adrenal gland cancer	3.96e-06	4.38e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—POMC—adrenal gland cancer	3.91e-06	4.32e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—POMC—adrenal gland cancer	3.91e-06	4.32e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—EGFR—adrenal gland cancer	3.89e-06	4.3e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PTGS2—adrenal gland cancer	3.88e-06	4.29e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	3.87e-06	4.28e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—EGFR—adrenal gland cancer	3.87e-06	4.28e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—BRAF—adrenal gland cancer	3.86e-06	4.27e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—BRAF—adrenal gland cancer	3.86e-06	4.27e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PTGS2—adrenal gland cancer	3.85e-06	4.26e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CTNNB1—adrenal gland cancer	3.83e-06	4.24e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—POMC—adrenal gland cancer	3.75e-06	4.15e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—EGFR—adrenal gland cancer	3.74e-06	4.14e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—EGFR—adrenal gland cancer	3.74e-06	4.14e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PTGS2—adrenal gland cancer	3.73e-06	4.12e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PTGS2—adrenal gland cancer	3.73e-06	4.12e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—POMC—adrenal gland cancer	3.66e-06	4.05e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—EGFR—adrenal gland cancer	3.66e-06	4.04e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—EGFR—adrenal gland cancer	3.53e-06	3.91e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	3.46e-06	3.82e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—POMC—adrenal gland cancer	3.45e-06	3.82e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	3.44e-06	3.81e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—POMC—adrenal gland cancer	3.42e-06	3.78e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—EGFR—adrenal gland cancer	3.42e-06	3.78e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—EGFR—adrenal gland cancer	3.42e-06	3.78e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	3.41e-06	3.77e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—TP53—adrenal gland cancer	3.41e-06	3.77e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	3.4e-06	3.76e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	3.35e-06	3.71e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GNAS—adrenal gland cancer	3.35e-06	3.71e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	3.29e-06	3.64e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TP53—adrenal gland cancer	3.26e-06	3.61e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—EGFR—adrenal gland cancer	3.26e-06	3.61e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—EGFR—adrenal gland cancer	3.16e-06	3.49e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—EGFR—adrenal gland cancer	3.16e-06	3.49e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TP53—adrenal gland cancer	3.07e-06	3.39e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—EGFR—adrenal gland cancer	3.03e-06	3.36e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	2.99e-06	3.31e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTGS2—adrenal gland cancer	2.92e-06	3.23e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CTNNB1—adrenal gland cancer	2.88e-06	3.19e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CTNNB1—adrenal gland cancer	2.79e-06	3.09e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CTNNB1—adrenal gland cancer	2.79e-06	3.09e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	2.75e-06	3.04e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	2.74e-06	3.03e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	2.73e-06	3.02e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	2.73e-06	3.02e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	2.7e-06	2.99e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	2.7e-06	2.98e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TP53—adrenal gland cancer	2.55e-06	2.82e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	2.3e-06	2.54e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	2.29e-06	2.53e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EGFR—adrenal gland cancer	2.28e-06	2.53e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	2.27e-06	2.51e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	2.26e-06	2.5e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—POMC—adrenal gland cancer	2.26e-06	2.5e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EGFR—adrenal gland cancer	2.21e-06	2.44e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EGFR—adrenal gland cancer	2.21e-06	2.44e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TP53—adrenal gland cancer	1.92e-06	2.12e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TP53—adrenal gland cancer	1.86e-06	2.05e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TP53—adrenal gland cancer	1.86e-06	2.05e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	1.8e-06	1.99e-05	CbGpPWpGaD
